Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

This, however, sometimes backfires. "We observed that increased expression of this gene damages β-cells, which in turn leads to reduced insulin secretion and the onset of diabetes," Harada said.

Breakthrough studies at the ADA highlight VX-880 stem cell therapy, drastically reducing insulin dependency for type 1 diabetes patients.

CHICAGO — Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, according to a speaker at the American ...

"As I think about my patients and the unmet need in the type 1 diabetes community, the results we've seen so far for restoring endogenous insulin secretion with a stem cell-derived islet therapy ...

As treatments for type 2 diabetes increasingly focus on GLP-1–based drugs, this study opens the door to using oxytocin or similar compounds to naturally enhance the body's own insulin-producing ...

Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices for insulin injections. The Forum for Injection Technique and Therapy ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 diabetes, according to a new preclinical study. With further testing, the ...

The FDA has approved Merilog, a new fast-acting insulin biosimilar for managing blood sugar in people with diabetes, marking the first such biosimilar to receive federal approval.

Diabetes drug development gets an advance in study that shows Inceptor binds excess insulin within the beta cell and directs it towards degradation.